SCHEMBL5201482

SCHEMBL5201482

CS(=O)(=O)n1ccc2ccc(O)cc21

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.59
HTR6 P50406 8/20 0.56
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
FABP4 P15090 3/20 0.38
CDC7 O00311 1/20 0.38
CDK2 P24941 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RAPGEF4 Q8WZA2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30376169 0.83 BACE1 (0.47) BACE1HTR6MEN1KMT2AFABP4
SCHEMBL21240885 0.80 HTR6 (0.58) BACE1HTR6MEN1KMT2AFABP4
SCHEMBL2357841 0.79 HTR6 (0.56) BACE1HTR6MEN1KMT2AMAPT
SCHEMBL7252893 0.79 HTR6 (0.56) BACE1HTR6MEN1KMT2AFABP4
SCHEMBL29496836 0.79 HTR6 (0.56) BACE1HTR6MEN1KMT2AFABP4
SCHEMBL30622545 0.78 HTR6 (0.52) BACE1HTR6MEN1KMT2AFABP4
SCHEMBL5206534 0.78 HTR6 (0.52) BACE1HTR6MEN1KMT2AFABP4
SCHEMBL29560090 0.77 HTR6 (0.68) HTR6MEN1KMT2AHSD17B1HSD17B2
SCHEMBL17597401 0.77 HTR6 (0.68) HTR6MEN1KMT2AHSD17B1HSD17B2
SCHEMBL15084664 0.76 HTR6 (0.63) BACE1HTR6MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed